Scholl et al., 2005 - Google Patents
Polysaccharide‐Degrading PhagesScholl et al., 2005
- Document ID
- 4228629404903454954
- Author
- Scholl D
- Merril C
- Publication year
- Publication venue
- Phages: Their Role in Bacterial Pathogenesis and Biotechnology
External Links
Snippet
This chapter discusses some of the recent developments and ideas and focuses on phages that possess virion‐bound capsule depolymerization activities rather than those that simply bind to surface carbohydrate structures. The best‐characterized polysaccharide‐degrading …
- 239000002775 capsule 0 abstract description 50
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Drulis-Kawa et al. | Bacteriophages and phage-derived proteins–application approaches | |
| Goodridge | Designing phage therapeutics | |
| CN105440139B (en) | Antimicrobial | |
| Pan et al. | Identification of three podoviruses infecting Klebsiella encoding capsule depolymerases that digest specific capsular types | |
| Rakhuba et al. | Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell | |
| Latka et al. | Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process | |
| Schmelcher et al. | Bacteriophage endolysins as novel antimicrobials | |
| Karumidze et al. | Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca | |
| EP1305038B1 (en) | Bacteriophage having multiple host range | |
| EP2847323B1 (en) | A bacteriophage for biocontrol of salmonella and in the manufacturing or processing of foods | |
| KR101101604B1 (en) | Bacteriophage kills pathogenic gut bacteria | |
| Ajuebor et al. | Bacteriophage endolysins and their applications | |
| Yang et al. | ClyJ is a novel pneumococcal chimeric lysin with a cysteine-and histidine-dependent amidohydrolase/peptidase catalytic domain | |
| Kim et al. | Characterization of Klebsiella pneumoniae bacteriophages, KP1 and KP12, with deep learning-based structure prediction | |
| KR20130087118A (en) | Podoviridae bacteriophage having killing activity specific to gram negative bacteria | |
| Scholl et al. | Polysaccharide‐Degrading Phages | |
| Lee et al. | A novel lysozyme from Xanthomonas oryzae phage ϕXo411 active against Xanthomonas and Stenotrophomonas | |
| KR20190138025A (en) | Novel Streptococcus suis bacteriophage Str-SUP-1 and its use for preventing proliferation of Streptococcus suis | |
| CN118389466A (en) | A kind of acinetobacter phage depolymerase and its preparation method and application | |
| CN115927270B (en) | Staphylococcus aureus phage lyase, variant thereof and application thereof | |
| Esmael et al. | Biocontrol of Acinetobacter baumannii-S-MH using bacteriophages isolated from sewage water | |
| Wan et al. | Characterization of vB_SalS_PSa2, a T5-like Demerecviridae bacteriophage, and its potential use in food matrices | |
| Veiga-Crespo et al. | Advantages and disadvantages in the use of antibiotics or phages as therapeutic agents | |
| Biswas et al. | Beyond antibiotics: exploring the potential of bacteriophages and phage therapy | |
| Williams et al. | Host-phage interactions and modeling for therapy |